119 related articles for article (PubMed ID: 1683882)
1. Clinical evaluation of the efficacy and safety of noberastine, a new H1 antagonist, in seasonal allergic rhinitis: a placebo-controlled, dose-response study.
Knight A; Drouin MA; Yang WH; Alexander M; Del Carpio J; Arnott WS
J Allergy Clin Immunol; 1991 Dec; 88(6):926-34. PubMed ID: 1683882
[TBL] [Abstract][Full Text] [Related]
2. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
Day JH; Briscoe M; Widlitz MD
J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis.
Hampel FC; Martin BG; Dolen J; Travers S; Karcher K; Holton D
Am J Rhinol; 1999; 13(1):55-62. PubMed ID: 10088031
[TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
[TBL] [Abstract][Full Text] [Related]
5. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis.
Meltzer EO; Weiler JM; Widlitz MD
J Allergy Clin Immunol; 1996 Feb; 97(2):617-26. PubMed ID: 8621847
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis.
Del Carpio J; Kabbash L; Turenne Y; Prevost M; Hebert J; Bedard PM; Nedilski M; Gutkowski A; Schulz J
J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):741-6. PubMed ID: 2572617
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study.
Meltzer EO; Casale TB; Gold MS; O'Connor R; Reitberg D; del Rio E; Weiler JM; Weiler K
Ann Allergy Asthma Immunol; 2003 Jan; 90(1):79-86. PubMed ID: 12546342
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis.
Gutkowski A; Bedard P; Del Carpio J; Hebert J; Prevost M; Schulz J; Turenne Y; Yeadon C
J Allergy Clin Immunol; 1988 May; 81(5 Pt 1):902-7. PubMed ID: 2897388
[TBL] [Abstract][Full Text] [Related]
10. Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis.
Bédard PM; Del Carpio J; Drouin MA; Yang W; Hébert J; Lavoie A; Prévost M; Turenne Y; PetitClerc C; Lorber R
Clin Ther; 1992; 14(2):268-75. PubMed ID: 1351796
[TBL] [Abstract][Full Text] [Related]
11. A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model.
Weiler JM; Meltzer EO; Benson PM; Weiler K; Widlitz MD; Freitag J
J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):972-80. PubMed ID: 7798545
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
Hampel F; Howland W; Van Bavel J; Ratner P
J Investig Allergol Clin Immunol; 2004; 14(1):56-63. PubMed ID: 15160443
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
Saint-Martin F; Dumur JP; Pérez I; Izquierdo I;
J Investig Allergol Clin Immunol; 2004; 14(1):34-40. PubMed ID: 15160440
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
Lockey RF; Widlitz MD; Mitchell DQ; Lumry W; Dockhorn R; Woehler T; Grossman J
Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.
Casale TB; Andrade C; Qu R
Allergy Asthma Proc; 1999; 20(3):193-8. PubMed ID: 10389553
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Ratner P; Hampel F; Van Bavel J; Howland W
Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
Berger WE; Schenkel EJ; Mansfield LE;
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
[TBL] [Abstract][Full Text] [Related]
19. Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial.
Dahl R; Pedersen B; Larsen B
Rhinology; 1995 Sep; 33(3):121-5. PubMed ID: 8560160
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of levocetirizine in seasonal allergic rhinitis.
Leynadier F; Mees K; Arendt C; Pinelli ME
Acta Otorhinolaryngol Belg; 2001; 55(4):305-12. PubMed ID: 11859651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
